Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Daiichi-Merck, Wegovy, Takeda CEO—Fierce Pharma Asia
The FDA rejected Daiichi and Merck's antibody-drug conjugate. Novo's Wegovy won its China nod. Takeda CEO is still open to China deal. Plus more.
Angus Liu
Jun 28, 2024 8:40am
Sponsored
Navigating the Patient Support Paradox
Jun 24, 2024 8:00am
Rovi receives offers for potential sale of €2B-plus CDMO group
Jun 27, 2024 2:21pm
SK Bioscience ponies up $244M for 60% stake in IDT Biologika
Jun 27, 2024 11:50am
Purdue bankruptcy reorg falls flat at Supreme Court
Jun 27, 2024 11:36am
AbbVie's Epkinly follows Roche's Lunsumio into FL
Jun 27, 2024 10:21am
Manufacturing News
Kite will evaluate Cellares' cell therapy manufacturing platform
Jun 27, 2024 8:00am
FDA rejects Merck's first ADC in Daiichi partnership
Jun 26, 2024 10:56pm
EuroAPI telegraphs 2 site sales, hundreds of layoffs
Jun 26, 2024 3:37pm
GenScript's ProBio CDMO debuts new gene therapy production plant
Jun 26, 2024 9:03am
See More Manufacturing News